[CLINICAL USE OF THE ANTIBIOTIC OLIVOMYCIN].
D000900:Anti-Bacterial Agents; D000970:Antineoplastic Agents; D004407:Dysgerminoma; D005260:Female; D005354:Fibrosarcoma; D006801:Humans; D008175:Lung Neoplasms; D016403:Lymphoma, Large B-Cell, Diffuse; D008228:Lymphoma, Non-Hodgkin; D008545:Melanoma; D009369:Neoplasms / Q000628:therapy*; D009848:Olivomycins; D010051:Ovarian Neoplasms; D012509:Sarcoma; D013274:Stomach Neoplasms; D002583:Uterine Cervical Neoplasms
D000900:Anti-Bacterial Agents; D000970:Antineoplastic Agents; D009848:Olivomycins
ANTIBIOTICS; ANTINEOPLASTIC AGENTS; CERVIX NEOPLASMS; DISGERMINOMA; FIBROSARCOMA; LUNG NEOPLASMS; LYMPHOSARCOMA; MELANOMA; NEOPLASM THERAPY; SARCOMA, RETICULUM CELL; STOMACH NEOPLASMS
KLINICHESKOE PRIMENENIE ANTIBIOTIKA OLIVOMITSINA.